Financials
- Market Capitalization 479.26 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.83
ratio cours/chiffre d'affaires
4.36
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2866 | MNPR Monopar Therapeutics Inc. - Common Stock | 72.08 USD | -6.45% | -7.92% | -31.35% | +31.97% | 483.81 M USD | ||
| 2868 | VALN Valneva SE - American Depositary Shares | 5.56 USD | -6.24% | -5.28% | -15.76% | -46.33% | 482.44 M USD | ||
| 2880 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.57 USD | -5.99% | +0.64% | -13.26% | -24.52% | 474.65 M USD | ||
| 2883 | ALT Altimmune, Inc. - Common Stock | 2.43 USD | -5.08% | -7.95% | -26.36% | -38.94% | 472.68 M USD |